- AGEN PD-1 antibody (AGEN2034) shows early signs of clinical activity in patients with cervical cancer
- AGEN PD-1 & CTLA-4 (AGEN1884) is the most advanced combination in 2L cervical cancer
PR Newswire
LEXINGTON, Mass., Oct. 9, 2018
PR Newswire
LEXINGTON, Mass., Oct. 9, 2018
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey